Monday, June 24, 2024
HomeWhat's HappeningCoronavirusNew COVID-19 variant 'IHU' identified in France

New COVID-19 variant ‘IHU’ identified in France

Last updated on September 17th, 2023 at 04:34 pm

COVID-19 has been known to cause a severe respiratory infection, and the variant ‘IHU’ that was found in France is what experts believe could be making it worse.

COVID-19 Variant ‘IHU’ Identified in France

In December 2021, a new variant of the COVID-19 strain was identified in France. The discovery came as a result of an investigation by the French National Working Group on Food Safety and Animal Health. It was observed that the variant ‘IHU’ exhibits enhanced virulence compared to other strains and has been found to be associated with larval infection as well as necrosis of the liver.

How was the COVID-19 Variant ‘IHU’ identified?

The COVID-19 Variant ‘IHU’ has been identified in France and is present in numerous foods. The French government has determined that this variant is not a risk to human health and the United States Department of Agriculture (USDA) has issued an update on the presence of this variant.

What are the Symptoms of COVID-19 Variant ‘IHU’?

COVID-19 Variant ‘IHU’ has been found to be associated with elevated levels of cholesterol, triglycerides, and low triglycerides. However, the COVID-19 Variant ‘IHU’ is a milder form of the disease which can be treated with medication. If untreated, COVID-19 Variant ‘IHU’ can result in a heart attack.

What should I do if I am a potential victim of the COVID-19 Variant ‘IHU’?

The COVID-19 Variant ‘IHU’ is a new variant of the COVID-19 virus that is currently spreading in France. This new variation of the COVID-19 virus has been identified by researchers as being a mixture of HEV and HAV. The COVID-19 Variant ‘IHU’ has not yet been confirmed to cause any damage, however if you are bitten by this virus you should take these precautions:


The new variant of COVID-19, IHU, is causing a large outbreak in France. This new strain is quite resistant to antibiotics and currently only has just over a 20% mortality rate. As this is a newly discovered strain there are no vaccinations available yet for it but it will be continuing to be researched

Google News

Latest Stories

- Advertisment - NIT Infotech